126 related articles for article (PubMed ID: 31150018)
21. Transfer of the ADA gene into bone marrow cells and peripheral blood lymphocytes for the treatment of patients affected by ADA-deficient SCID.
Bordignon C; Mavilio F; Ferrari G; Servida P; Ugazio AG; Notarangelo LD; Gilboa E; Rossini S; O'Reilly RJ; Smith CA
Hum Gene Ther; 1993 Aug; 4(4):513-20. PubMed ID: 8399494
[TBL] [Abstract][Full Text] [Related]
22. Autologous peripheral blood progenitor cell transplantation with <2 x 10(6) CD34(+)/kg: an analysis of variables concerning mobilisation and engraftment.
Villalón L; Odriozola J; Laraña JG; Zamora C; Pérez de Oteyza J; Jodra MH; López J; Herrera P; Roldán E; Ramos ML; Ramos P; Navarro JL
Hematol J; 2000; 1(6):374-81. PubMed ID: 11920217
[TBL] [Abstract][Full Text] [Related]
23.
Chandra S; Cristofori P; Fonck C; O'Neill CA
Toxicol Pathol; 2019 Jul; 47(5):656-660. PubMed ID: 31064282
[TBL] [Abstract][Full Text] [Related]
24. The Cape Town experience with haematopoietic stem cell transplantation: the paediatric programme.
Roux P; Novitzky N
S Afr Med J; 2000 Aug; 90(8):804-11. PubMed ID: 11022631
[TBL] [Abstract][Full Text] [Related]
25. Haploidentical peripheral blood and marrow stem cell transplantation in nine cases of primary immunodeficiency.
Lanfranchi A; Verardi R; Tettoni K; Neva A; Mazzolari E; Pennacchio M; Pasic S; Ugazio AG; Albertini A; Porta F
Haematologica; 2000 Nov; 85(11 Suppl):41-6. PubMed ID: 11268323
[TBL] [Abstract][Full Text] [Related]
26. Autologous Ex Vivo Lentiviral Gene Therapy for Adenosine Deaminase Deficiency.
Kohn DB; Booth C; Shaw KL; Xu-Bayford J; Garabedian E; Trevisan V; Carbonaro-Sarracino DA; Soni K; Terrazas D; Snell K; Ikeda A; Leon-Rico D; Moore TB; Buckland KF; Shah AJ; Gilmour KC; De Oliveira S; Rivat C; Crooks GM; Izotova N; Tse J; Adams S; Shupien S; Ricketts H; Davila A; Uzowuru C; Icreverzi A; Barman P; Campo Fernandez B; Hollis RP; Coronel M; Yu A; Chun KM; Casas CE; Zhang R; Arduini S; Lynn F; Kudari M; Spezzi A; Zahn M; Heimke R; Labik I; Parrott R; Buckley RH; Reeves L; Cornetta K; Sokolic R; Hershfield M; Schmidt M; Candotti F; Malech HL; Thrasher AJ; Gaspar HB
N Engl J Med; 2021 May; 384(21):2002-2013. PubMed ID: 33974366
[TBL] [Abstract][Full Text] [Related]
27. Paclitaxel chemotherapy after autologous stem-cell transplantation and engraftment of hematopoietic cells transduced with a retrovirus containing the multidrug resistance complementary DNA (MDR1) in metastatic breast cancer patients.
Cowan KH; Moscow JA; Huang H; Zujewski JA; O'Shaughnessy J; Sorrentino B; Hines K; Carter C; Schneider E; Cusack G; Noone M; Dunbar C; Steinberg S; Wilson W; Goldspiel B; Read EJ; Leitman SF; McDonagh K; Chow C; Abati A; Chiang Y; Chang YN; Gottesman MM; Pastan I; Nienhuis A
Clin Cancer Res; 1999 Jul; 5(7):1619-28. PubMed ID: 10430060
[TBL] [Abstract][Full Text] [Related]
28. Outcomes in two Japanese adenosine deaminase-deficiency patients treated by stem cell gene therapy with no cytoreductive conditioning.
Otsu M; Yamada M; Nakajima S; Kida M; Maeyama Y; Hatano N; Toita N; Takezaki S; Okura Y; Kobayashi R; Matsumoto Y; Tatsuzawa O; Tsuchida F; Kato S; Kitagawa M; Mineno J; Hershfield MS; Bali P; Candotti F; Onodera M; Kawamura N; Sakiyama Y; Ariga T
J Clin Immunol; 2015 May; 35(4):384-98. PubMed ID: 25875699
[TBL] [Abstract][Full Text] [Related]
29. The impact of CD34+ cell dose on platelet engraftment in pediatric patients following unmanipulated haploidentical blood and marrow transplantation.
Chang YJ; Xu LP; Liu DH; Liu KY; Han W; Chen YH; Wang Y; Chen H; Wang JZ; Zhang XH; Zhao XY; Huang XJ
Pediatr Blood Cancer; 2009 Dec; 53(6):1100-6. PubMed ID: 19743519
[TBL] [Abstract][Full Text] [Related]
30. The use of adjusted ideal body weight for overweight patients undergoing HPC mobilisation for autologous transplantation.
Hicks C; Trickett A; Kwan YL; Ramanathan S
Ann Hematol; 2012 Nov; 91(11):1795-801. PubMed ID: 22836946
[TBL] [Abstract][Full Text] [Related]
31. Donor characteristics and intraoperative total nucleated cell count influence hematopoietic progenitor cell yield of healthy donor bone marrow grafts.
Kalin J; Nguyen ATH; Oshrine B
Pediatr Blood Cancer; 2021 Apr; 68(4):e28902. PubMed ID: 33484054
[TBL] [Abstract][Full Text] [Related]
32. Loss of marrow reserve from dose-intensified chemotherapy results in impaired hematopoietic reconstitution after autologous transplantation: CD34(+), CD34(+)38(-), and week-6 CAFC assays predict poor engraftment.
Robinson SN; Freedman AS; Neuberg DS; Nadler LM; Mauch PM
Exp Hematol; 2000 Dec; 28(12):1325-33. PubMed ID: 11146154
[TBL] [Abstract][Full Text] [Related]
33. Effect of ex vivo culture of CD34+ bone marrow cells on immune reconstitution of XSCID dogs following allogeneic bone marrow transplantation.
Kennedy DR; McLellan K; Moore PF; Henthorn PS; Felsburg PJ
Biol Blood Marrow Transplant; 2009 Jun; 15(6):662-70. PubMed ID: 19450750
[TBL] [Abstract][Full Text] [Related]
34. Busulfan Pharmacokinetics in Adenosine Deaminase-Deficient Severe Combined Immunodeficiency Gene Therapy.
Bradford KL; Liu S; Krajinovic M; Ansari M; Garabedian E; Tse J; Wang X; Shaw KL; Gaspar HB; Candotti F; Kohn DB
Biol Blood Marrow Transplant; 2020 Oct; 26(10):1819-1827. PubMed ID: 32653625
[TBL] [Abstract][Full Text] [Related]
35. Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH).
Koç ON; Day J; Nieder M; Gerson SL; Lazarus HM; Krivit W
Bone Marrow Transplant; 2002 Aug; 30(4):215-22. PubMed ID: 12203137
[TBL] [Abstract][Full Text] [Related]
36. An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy.
Weaver CH; Hazelton B; Birch R; Palmer P; Allen C; Schwartzberg L; West W
Blood; 1995 Nov; 86(10):3961-9. PubMed ID: 7579367
[TBL] [Abstract][Full Text] [Related]
37. CD34+ cell responsiveness to stromal cell-derived factor-1alpha underlies rate of engraftment after peripheral blood stem cell transplantation.
Marquez-Curtis LA; Turner AR; Larratt LM; Letcher B; Lee SF; Janowska-Wieczorek A
Transfusion; 2009 Jan; 49(1):161-9. PubMed ID: 18954402
[TBL] [Abstract][Full Text] [Related]
38. Bone marrow gene transfer in three patients with adenosine deaminase deficiency.
Hoogerbrugge PM; van Beusechem VW; Fischer A; Debree M; le Deist F; Perignon JL; Morgan G; Gaspar B; Fairbanks LD; Skeoch CH; Moseley A; Harvey M; Levinsky RJ; Valerio D
Gene Ther; 1996 Feb; 3(2):179-83. PubMed ID: 8867866
[TBL] [Abstract][Full Text] [Related]
39. Combined bone marrow and peripheral blood progenitor cell autografts for patients with poor mobilization.
Sinitsyn Y; Malone A; Mandeli J; Grosskreutz C; Osman K; Scigliano E; Shi P; Isola L
Cytotherapy; 2009; 11(4):457-63. PubMed ID: 19499401
[TBL] [Abstract][Full Text] [Related]
40. Engraftment defect of cytokine-cultured adult human mobilized CD34(+) cells is related to reduced adhesion to bone marrow niche elements.
Kallinikou K; Anjos-Afonso F; Blundell MP; Ings SJ; Watts MJ; Thrasher AJ; Linch DC; Bonnet D; Yong KL
Br J Haematol; 2012 Sep; 158(6):778-87. PubMed ID: 22816563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]